AU7022198A - Vanadium complexes and derivatives thereof and methods related thereto - Google Patents

Vanadium complexes and derivatives thereof and methods related thereto

Info

Publication number
AU7022198A
AU7022198A AU70221/98A AU7022198A AU7022198A AU 7022198 A AU7022198 A AU 7022198A AU 70221/98 A AU70221/98 A AU 70221/98A AU 7022198 A AU7022198 A AU 7022198A AU 7022198 A AU7022198 A AU 7022198A
Authority
AU
Australia
Prior art keywords
derivatives
methods related
vanadium complexes
vanadium
complexes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU70221/98A
Inventor
Pierre Lemieux
Philip Toleikis
Zaihui Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angiotech Pharmaceuticals Inc
Original Assignee
Angiotech Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angiotech Pharmaceuticals Inc filed Critical Angiotech Pharmaceuticals Inc
Publication of AU7022198A publication Critical patent/AU7022198A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/38—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/005—Compounds of elements of Group 5 of the Periodic Table without metal-carbon linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU70221/98A 1997-04-24 1998-04-24 Vanadium complexes and derivatives thereof and methods related thereto Abandoned AU7022198A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4479397P 1997-04-24 1997-04-24
US60044793 1997-04-24
PCT/CA1998/000376 WO1998049173A1 (en) 1997-04-24 1998-04-24 Vanadium complexes and derivatives thereof and methods related thereto

Publications (1)

Publication Number Publication Date
AU7022198A true AU7022198A (en) 1998-11-24

Family

ID=21934368

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70221/98A Abandoned AU7022198A (en) 1997-04-24 1998-04-24 Vanadium complexes and derivatives thereof and methods related thereto

Country Status (4)

Country Link
EP (1) EP0984971A1 (en)
AU (1) AU7022198A (en)
CA (1) CA2291775A1 (en)
WO (1) WO1998049173A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000024730A1 (en) * 1998-10-28 2000-05-04 The University Of British Columbia Organic vanadium(iii) complexes and their use
US6878388B1 (en) * 2000-11-15 2005-04-12 Parker Hughes Institute Vanadium compounds for treating proliferative cell disorders
US20220370472A1 (en) * 2019-06-24 2022-11-24 Hunan Fangshengtai Medical Technology Co., Ltd. New application of metal complex

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678622B1 (en) * 1991-07-03 1994-11-18 Adir NEW VANADIUM COMPLEXES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
US5527790A (en) * 1991-09-30 1996-06-18 The University Of British Columbia Bis(maltolato)oxovanadium compositions for the treatment of elevated blood sugar
US5300496A (en) * 1991-09-30 1994-04-05 The University Of British Columbia Complexed vanadium for the treatment of diabetes mellitus
US5565491A (en) * 1994-01-31 1996-10-15 Bristol-Myers Squibb Company Use of phosphotyrosine phospatase inhibitors for controlling cellular proliferation

Also Published As

Publication number Publication date
CA2291775A1 (en) 1998-11-05
WO1998049173A1 (en) 1998-11-05
EP0984971A1 (en) 2000-03-15

Similar Documents

Publication Publication Date Title
AU9790198A (en) Compounds and methods
AU1151099A (en) Azaoxindole derivatives
AU1825899A (en) Dota-biotin derivatives
AU7935398A (en) Diaminorhodamine derivatives
AU6117998A (en) 3-oxadiazolylquinoxaline derivatives
AU1735497A (en) Sulfonylureidopyrazole derivatives
AU3867997A (en) Chromene-3-carboxylate derivatives
AU2216495A (en) N-cyanoaryl nitrogen heterocycles
AU4703099A (en) Macromolecule-lipid complexes and methods for making and using
AU2956097A (en) Alkylaminobenzothiazole and -benzoxazole derivatives
EP1008579A3 (en) Cyclopentenebutanol derivatives
AU4268496A (en) Targeting complexes and use thereof
AU4962097A (en) 2-methoxyphenylpiperazine derivatives
AU6184499A (en) Organic vanadium(iii) complexes and their use
AU1670297A (en) Benzofuran-7-yluracil derivatives and herbicides
AU1174199A (en) Biphenylamidine derivatives
AU6729498A (en) Thiazolimine derivatives
AU1793197A (en) Pyrazole-4-yl-hetaroyl derivatives
AU9650398A (en) Piperazine-cyclodextrin complexes
AU2042897A (en) Aminopyridine derivatives
AU3290197A (en) Halopropargyl inclusion complexes
AU3685097A (en) N-benzylazolium derivatives
AU1600297A (en) Aryl derivatives
AU7022198A (en) Vanadium complexes and derivatives thereof and methods related thereto
AU3107497A (en) Asialotrisaccharide moranoline derivatives and drugs